Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Oncospace

K-Number: K242748 · 2025-04-11

ApplicantOncospace, Inc.
Decision Date2025-04-11
Product CodeMUJ
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Oncospace is a medical device manufactured by Oncospace, Inc.. It received FDA 510(k) clearance on 2025-04-11 under approval number K242748. The device is classified under product code MUJ. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Oncospace?

Oncospace is a medical device that received FDA 510(k) clearance on 2025-04-11. It is manufactured by Oncospace, Inc.. The 510(k) number is K242748.

When was Oncospace approved by the FDA?

Oncospace received FDA 510(k) clearance on 2025-04-11, under approval number K242748.

What company makes Oncospace?

Oncospace is manufactured by Oncospace, Inc..

What is the FDA product code for Oncospace?

The FDA product code for Oncospace is MUJ.

Other Devices by Oncospace, Inc.

K202284Oncospace K222803Oncospace

Related Devices (Code: MUJ)

K162370syngo.via RT Image SuiteSiemens Medical Solutions USA, Inc. K161136Precision Treatment Planning SystemAccuray Incorporated K160093RayStationRaySearch Laboratories AB (PUBL) K151435MRCATPhilips Medical Systems MR Finland K153368Radiance V3Gmv Soluciones Globales Internet S.A.U. K170750RT Elements, Cranial SRS, Spine SRS, Multiple Brain Mets SRS, RT QA, Adaptive Hybrid Surgery Analysis, Dose ReviewBrainlab AG

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑